ÂÜÀòÂÒÂ×

Emily Farrington is an experienced professional in health technology assessment, currently serving as the Associate Director for HTA Europe at Otsuka Pharmaceutical Companies Europe since July 2021, after progressing through roles as Senior HTA Manager and HTA Manager. Prior to joining Otsuka, Emily worked as HTA Manager for AbbVie in the UK and held multiple positions at Adelphi Values, culminating in the role of Associate Director. Early in their career, Emily contributed as a Healthcare Assistant at Derian House Children's Hospice. Educational qualifications include a Master of Public Health from the London School of Hygiene and Tropical Medicine, a European Market Access University Diploma from Aix-Marseille Université, and a Bachelor of Science in Biology from The University of Manchester.